Details for Patent: 6,255,325
✉ Email this page to a colleague
Summary for Patent: 6,255,325
Title: | Chronic, bolus administration of D-threo methylphenidate |
Abstract: | Chronic bolus administration of D-threo methylphenidate is provided. The administration of the D-threo isomer eliminates adverse side effects associated with the DL racemate, and provides improved effectiveness. The compositions and methods of the invention are useful in treating nervous system disorders including attention deficit disorder, attention deficit hyperactivity disorder, and cognitive decline associated with systemic diseases such as acquired immunodeficiency syndrome. |
Inventor(s): | Dariani; Maghsoud M. (Fanwood, NJ), Zeitlin; Andrew L. (Millington, NJ), Zeldis; Jerome B. (Princeton, NJ) |
Assignee: | Celgene Corporation (Warren, NJ) |
Application Number: | 09/337,310 |
Patent Claim Types: see list of patent claims | Use; Compound; Dosage form; |
Drugs Protected by US Patent 6,255,325
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,255,325
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 306266 | ⤷ Try a Trial | |||
Austria | 368458 | ⤷ Try a Trial | |||
Australia | 2002318302 | ⤷ Try a Trial | |||
Australia | 738521 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |